Johnson & Johnson on Friday said it would split into two companies , hiving off its consumer health division that sells Band-Aids and Baby Powder from its pharmaceuticals and medical devices business. The separate companies will have to divide up …
Johnson & Johnson said it has settled most of the lawsuits it faced by thousands of men who claimed its anti-psychotic drug Risperdal caused them to develop excessive breast tissue and disclosed that it recorded $800 million in expenses in …
Johnson & Johnson’s Janssen unit was hit with an $8 billion punitive-damages verdict — the largest jury award in the U.S. this year — over its alleged mishandling of an anti-psychotic drug blamed for causing adolescent boys to grow female-sized …
South Carolina’s highest court further reduced the penalty against a Johnson & Johnson subsidiary accused of deceptive marketing of an anti-psychotic drug. The decision was to substitute the same verdict the court reached in February in order to correct a …
South Carolina’s Supreme Court ordered Johnson & Johnson to pay a penalty of $136 million, upholding a jury’s finding that the drugmaker’s Janssen unit had improperly marketed its anti-psychotic drug Risperdal and concealed its risks. A trial court had earlier …
The Arkansas Supreme Court overturned a $1.2 billion judgment against Johnson & Johnson in a lawsuit challenging the drug maker’s marketing of the antipsychotic drug Risperdal. The agreement was the third-largest settlement with a drug maker in U.S. history. The …
